Towards the introduction of the 'Immunoscore'in the classification of malignant tumours

J Galon, B Mlecnik, G Bindea, HK Angell… - The Journal of …, 2014 - Wiley Online Library
Abstract The American Joint Committee on Cancer/Union Internationale Contre le Cancer
(AJCC/UICC) TNM staging system provides the most reliable guidelines for the routine …

Escape of human solid tumors from T–cell recognition: Molecular mechanisms and functional significance

FM Marincola, EM Jaffee, DJ Hicklin, S Ferrone - Advances in immunology, 1999 - Elsevier
Publisher Summary It is known for some time that malignant transformation of human cells
may be associated with the appearance of tumor associated antigens (TAA). Decades of …

[HTML][HTML] Cancer classification using the Immunoscore: a worldwide task force

J Galon, F Pagès, FM Marincola, HK Angell… - Journal of translational …, 2012 - Springer
Prediction of clinical outcome in cancer is usually achieved by histopathological evaluation
of tissue samples obtained during surgical resection of the primary tumor. Traditional tumor …

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

SA Rosenberg, JC Yang, DJ Schwartzentruber… - Nature medicine, 1998 - nature.com
The cloning of the genes encoding cancer antigens has opened new possibilities for the
treatment of patients with cancer. In this study, immunodominant peptides from the gp100 …

A human memory T cell subset with stem cell–like properties

L Gattinoni, E Lugli, Y Ji, Z Pos, CM Paulos… - Nature medicine, 2011 - nature.com
Immunological memory is thought to depend on a stem cell–like, self-renewing population of
lymphocytes capable of differentiating into effector cells in response to antigen re-exposure …

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou… - The Lancet, 2018 - thelancet.com
Background The estimation of risk of recurrence for patients with colon carcinoma must be
improved. A robust immune score quantification is needed to introduce immune parameters …

Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment

N Iida, A Dzutsev, CA Stewart, L Smith, N Bouladoux… - science, 2013 - science.org
The gut microbiota influences both local and systemic inflammation. Inflammation
contributes to development, progression, and treatment of cancer, but it remains unclear …

HLA B* 5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors

SA Migueles, MS Sabbaghian… - Proceedings of the …, 2000 - National Acad Sciences
A unique cohort of HIV-1-infected long term nonprogressors (LTNP) with normal CD4+ T cell
counts and< 50 copies/ml of plasma were prospectively recruited for study. HLA typing …

[HTML][HTML] gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma

DJ Schwartzentruber, DH Lawson… - … England Journal of …, 2011 - Mass Medical Soc
Background Stimulating an immune response against cancer with the use of vaccines
remains a challenge. We hypothesized that combining a melanoma vaccine with interleukin …

[HTML][HTML] The role of BRAF V600 mutation in melanoma

PA Ascierto, JM Kirkwood, JJ Grob, E Simeone… - Journal of translational …, 2012 - Springer
BRAF is a serine/threonine protein kinase activating the MAP kinase/ERK-signaling
pathway. About 50% of melanomas harbors activating BRAF mutations (over 90% V600E) …